Skip to main content
Krsnaa Diagnostics Limited logo

Krsnaa Diagnostics Limited — Investor Relations & Filings

Ticker · KRSNAA ISIN · INE08LI01020 LEI · 335800BHDTJRKNTQ1O55 BSE.NS Human health and social work activities
Filings indexed 626 across all filing types
Latest filing 2025-08-11 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS KRSNAA

About Krsnaa Diagnostics Limited

https://krsnaadiagnostics.com/

Krsnaa Diagnostics Limited is a specialized provider of diagnostic services, focusing on radiology and pathology. The company operates an extensive network of centers, primarily utilizing a Public-Private Partnership (PPP) model to deliver medical imaging and laboratory services. Its radiology portfolio includes Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, X-rays, and Mammography, while its pathology division offers a wide array of clinical laboratory tests. A core technical feature is its integrated tele-radiology platform, which facilitates remote image interpretation by specialists to ensure rapid reporting. The company emphasizes high-quality, affordable diagnostics, targeting both public health systems and private patients. Its operational model is built on large-scale infrastructure and advanced technological integration to provide accessible diagnostic solutions across diverse geographic regions.

Recent filings

Filing Released Lang Actions
Record Date
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of the outcome of a Board Meeting held on August 11, 2025, which includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. It contains an Independent Auditor's Review Report on these unaudited financial results, detailed financial tables, notes to the financial results, and disclosures about tax assessments and appeals. The document also mentions the Director's report and notice of the upcoming AGM but does not itself contain the full Annual Report. The presence of unaudited quarterly financial results with detailed financial data and auditor's review indicates this is an Interim / Quarterly Report. It is not a mere announcement or certification but contains substantive financial data and analysis for the quarter. Therefore, the correct classification is Interim / Quarterly Report (IR).
2025-08-11 English
Updates
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement dated August 11, 2025, reporting the outcome of a Board Meeting of Krsnaa Diagnostics Limited. It includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, along with a Director's report and notice of the upcoming AGM. The document contains an Independent Auditor's Review Report on the unaudited financial results, prepared under Indian Accounting Standard 34 for interim financial reporting, and detailed financial statements for the quarter. The presence of unaudited quarterly financial results, auditor's review, and detailed financial data confirms this is an Interim / Quarterly Report. It is not merely an announcement or a certification but contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-08-11 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of the outcome of a Board Meeting held on August 11, 2025, which includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. It also mentions the Director's report forming part of the Annual Report for the financial year 2024-25, notice of the 15th AGM, and continuation of a director's appointment. The document contains an Independent Auditor's Review Report on the unaudited financial results, detailed financial tables, notes to the financial results, and disclosures about tax assessments and appeals. The presence of unaudited quarterly financial results with detailed financial data and auditor's review indicates this is an Interim / Quarterly Report. The document is about quarterly financial results, not a full annual report, and it contains substantive financial data and analysis, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2025-08-11 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of the outcome of a Board Meeting held on August 11, 2025, which includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. It contains an Independent Auditor's Review Report on these unaudited financial results, detailed financial tables, notes to the financial results, and disclosures about tax assessments and appeals. The document is comprehensive, includes substantive financial data and analysis for a quarter, and is not merely an announcement or certification. The presence of quarterly unaudited financial results and auditor's review aligns with the characteristics of an Interim / Quarterly Report (IR). Therefore, the document should be classified as an Interim / Quarterly Report (IR).
2025-08-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about an upcoming Analyst/Institutional Investor Meeting. It contains details about the date, place, and mode of the meeting but does not include any financial data, report, or transcript. The document is short (2206 characters) and serves as a notification of a meeting rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-06 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, providing an update on a tender agreement executed by the company. It is addressed to stock exchanges and includes details about the contract awarded under a government initiative. The document is a regulatory announcement about a material event (tender update) rather than a financial report or detailed filing. It does not contain financial statements or detailed financial analysis. The length is about 3,034 characters, which is relatively short and consistent with a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.